Announcement of DNDi's annual report (2021) release

DNDi has released the 2021 Annual Report.

The 2021 Annual Report describes recent developments towards the realization of the core commitments of DNDi's 2021-2028 Strategic Plan. Progress has been made in 50 research and development (R & D) projects in 2021, especially in the area of FDA approval of fexinidazole, a treatment for African sleeping sickness, and clinical trials of five new compounds for squirrel mania. There has been great progress.

A detailed summary and PDF of the report can be found at this link .